抽象的

Topical Dosage Forms of different Drugs by FDA: A Bioequivalence Study

Satya Varali

The absorption rate of the test drug doesn't demonstrate a huge difference from the rate of absorption of the reference drug when administered at the same therapeutic dose of the active ingredient under comparable test conditions. The Pharmaceutical Development section gives a chance to present the information from the application of scientific approaches and risk management and from manufacturing process. First it as created for the original marketing application and second updated to support new information gained over the product lifecycle. The Pharmaceutical Development section is intended to provide a more extensive comprehension of the product and manufacturing process for analysts.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证

索引于

谷歌学术
打开 J 门
研究圣经
引用因子
宇宙IF
开放学术期刊索引 (OAJI)
学者指导
普布隆斯
国际创新期刊影响因子(IIJIF)
国际组织研究所 (I2OR)
宇宙
日内瓦医学教育与研究基金会
秘密搜索引擎实验室
欧洲酒吧

查看更多